Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthgrades for Professionals
Healthcare providers demonstrate different treatment approaches based on patient demographics and perceived medical knowledge, requiring systematic advocacy training.
Obstetrics & Gynecology May 27th 2025
Epoch Health
Previous research on omega-6 fatty acids has produced mixed results and often lacked clarity on how these fats affect cancer risk… this research is focused on clearing up those uncertainties.
Oncology, Medical April 29th 2025
Journal of the National Cancer Institute (JNCI)
A comprehensive analysis of 176,601 cancer cases demonstrates that long-acting reversible contraceptives offer a cancer risk profile comparable to oral contraceptives, with data showing a 20-30% reduction in gynecologic cancer risk and a modest increase in breast cancer risk that returns to baseline after cessation.
Obstetrics & Gynecology February 20th 2025
Oncology News Central (ONC)
The combination of imlunestrant plus abemaciclib demonstrated significant progression-free survival benefit across all subgroups, including patients with prior CDK4/6 inhibitor use and those with visceral metastases.
Oncology, Medical January 21st 2025
In a cohort of 601 women aged ≥65 years with low-risk breast cancer treated without radiotherapy, the 10-year local recurrence rate was 5.5%, with only 0.5% breast cancer-specific mortality.
Geriatrics January 21st 2025
Dana-Farber Cancer Institute
Latest clinical trial data suggests active monitoring may be a viable alternative to standard treatment for select low-risk DCIS patients, with comparable quality-of-life outcomes.